OBJECTIVE: To examine ethnic differences in adrenal androgen production, IGF-I, and IGFBP-1 and -3 in relation to bone age, insulin, and body composition in healthy prepubertal girls. METHODS: Serum levels of DHEA-S, androstenedione, IGF-I, and IGFBP-1 and -3 were examined in relation to bone age, insulin, and body composition (determined by dual-energy X-ray absorptiometry) in 47 (19 Caucasian, 9 African-American, 19 Mexican-American) healthy prepubertal girls aged 7.5-9.0 years. RESULTS: Age, weight, height, bone age, androstenedione, insulin, glucose:insulin ratios, and IGFBP-3 levels were not statistically different among groups. Mexican-American girls had higher % body fat than African-Americans or Caucasians (P < 0.001). DHEA-S levels in African-Americans were twofold higher than in Caucasians (P = 0.024), although their % body fat was not significantly different (16.1% and 19.4%, respectively; P = 0.138). DHEA-S levels in Mexican-American girls were intermediate. Bone age and weight were significant covariates for DHEA-S levels. Plasma IGF-I levels were also higher in African-American than in Caucasian or Mexican-American girls (P = 0.009). Covariance analysis showed that IGF-I levels were influenced mainly by ethnicity (P = 0.009) and were independent of bone age. Despite similar insulin levels among groups, IGFBP-1 levels were higher in Caucasians than in Mexican-Americans or African-Americans (P < 0.001). CONCLUSIONS: In healthy prepubertal girls, DHEA-S concentrations are higher in African-Americans than in Caucasians or Mexican-Americans, even before any clinical evidence of adrenarche. Furthermore, IGF-I concentrations are higher in African-American girls than in Caucasian or Mexican-American girls which may contribute to the higher DHEA-S levels observed. Conversely, higher DHEA-S and IGF-I levels in African-American girls may be indicative of an influence not only of gonadal but also of adrenal androgens on the GH/IGF-I axis.
OBJECTIVE: To examine ethnic differences in adrenal androgen production, IGF-I, and IGFBP-1 and -3 in relation to bone age, insulin, and body composition in healthy prepubertal girls. METHODS: Serum levels of DHEA-S, androstenedione, IGF-I, and IGFBP-1 and -3 were examined in relation to bone age, insulin, and body composition (determined by dual-energy X-ray absorptiometry) in 47 (19 Caucasian, 9 African-American, 19 Mexican-American) healthy prepubertal girls aged 7.5-9.0 years. RESULTS: Age, weight, height, bone age, androstenedione, insulin, glucose:insulin ratios, and IGFBP-3 levels were not statistically different among groups. Mexican-American girls had higher % body fat than African-Americans or Caucasians (P < 0.001). DHEA-S levels in African-Americans were twofold higher than in Caucasians (P = 0.024), although their % body fat was not significantly different (16.1% and 19.4%, respectively; P = 0.138). DHEA-S levels in Mexican-American girls were intermediate. Bone age and weight were significant covariates for DHEA-S levels. Plasma IGF-I levels were also higher in African-American than in Caucasian or Mexican-American girls (P = 0.009). Covariance analysis showed that IGF-I levels were influenced mainly by ethnicity (P = 0.009) and were independent of bone age. Despite similar insulin levels among groups, IGFBP-1 levels were higher in Caucasians than in Mexican-Americans or African-Americans (P < 0.001). CONCLUSIONS: In healthy prepubertal girls, DHEA-S concentrations are higher in African-Americans than in Caucasians or Mexican-Americans, even before any clinical evidence of adrenarche. Furthermore, IGF-I concentrations are higher in African-American girls than in Caucasian or Mexican-American girls which may contribute to the higher DHEA-S levels observed. Conversely, higher DHEA-S and IGF-I levels in African-American girls may be indicative of an influence not only of gonadal but also of adrenal androgens on the GH/IGF-I axis.
Authors: A B Sopher; J C Thornton; M E Silfen; A Manibo; S E Oberfield; J Wang; R N Pierson; L S Levine; M Horlick Journal: J Clin Endocrinol Metab Date: 2001-11 Impact factor: 5.958
Authors: Shana E McCormack; Alessandra Chesi; Jonathan A Mitchell; Sani M Roy; Diana L Cousminer; Heidi J Kalkwarf; Joan M Lappe; Vicente Gilsanz; Sharon E Oberfield; John A Shepherd; Soroosh Mahboubi; Karen K Winer; Andrea Kelly; Struan Fa Grant; Babette S Zemel Journal: J Bone Miner Res Date: 2016-12-02 Impact factor: 6.741
Authors: Tanya L Alderete; Courtney E Byrd-Williams; Claudia M Toledo-Corral; David V Conti; Marc J Weigensberg; Michael I Goran Journal: Obesity (Silver Spring) Date: 2010-09-30 Impact factor: 5.002
Authors: Tanya Agurs-Collins; Sabine Rohrmann; Catherine Sutcliffe; Jessica L Bienstock; Deborah Monsegue; Folasade Akereyeni; Gary Bradwin; Nader Rifai; Michael N Pollak; Elizabeth A Platz Journal: Cancer Causes Control Date: 2012-01-18 Impact factor: 2.506
Authors: Krista Casazza; Paul B Higgins; José R Fernández; Michael I Goran; Barbara A Gower Journal: J Clin Endocrinol Metab Date: 2008-09-09 Impact factor: 5.958
Authors: Claudia M Toledo-Corral; Christian K Roberts; Gabriel Q Shaibi; Christianne J Lane; Paul B Higgins; Jaimie N Davis; Marc J Weigensberg; Michael I Goran Journal: J Pediatr Endocrinol Metab Date: 2008-09 Impact factor: 1.634
Authors: Kristi L Watterberg; Susan R Hintz; Barbara Do; Betty R Vohr; Jean Lowe; Jamie E Newman; Dennis Wallace; Conra Backstrom Lacy; Elysia Poggi Davis; Douglas A Granger; Seetha Shankaran; Allison Payne; Rosemary D Higgins Journal: Pediatr Res Date: 2018-12-12 Impact factor: 3.756